Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 26, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

December 30, 2019

Conditions
Health Services for Transgender PersonsTransgender Persons
Interventions
DRUG

Testosterone injection

SQ or IM testosterone injections for pubertal induction of transgender male adolescents. Increasing doses per protocol at 3 month and 6 month follow up.

BEHAVIORAL

PedsQL questionnarie

Validated Pediatric Quality of Life questionnaire completed by subjects at baseline, 3 month and 6 month study visits.

OTHER

Masculinizing effects questionnaire

Subjects complete self-reported questionnaire at 3 month and 6 month study visits.

OTHER

Medication experience questionnaire

Subjects complete self-reported questionnaire at 3 month and 6 month study visits.

Trial Locations (1)

97239

Oregon Health and Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT03864913 - Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents | Biotech Hunter | Biotech Hunter